Skip to main content
Matthew Lazzara

Matthew Lazzara

Professor of Chemical Engineering, Chemical Engineering

Bio & Overview

Matt's research group studies fundamental and applied aspects of mammalian cell signaling and receptor trafficking processes. Signaling and cell phenotype regulation by the epidermal growth factor receptor (EGFR) and the protein tyrosine phosphatase SHP2, and the impact of such signaling on cancer cell response to targeted therapies, are areas of primary interest. More recently, the lab has begun working on two new classes of problems in the mammalian kidney involving receptor-mediated processes that maintain the normal glomerular filtration barrier and that enable the reabsorption of filtered proteins from the proximal tubule. In studying all of these problems, the lab employs a combination of experimental and computational modeling approaches.

Academic Information

Department
Chemical Engineering

Primary Education

  • B.S., undefinedUniversity of Floridanull
  • Ph.D., undefinedMassachusetts Institute of Technologynull
  • Postdoc, undefinedMassachusetts Institute of Technologynull

Other Affiliations

  • MSTP
  • BIMS
  • BIMS

Research Interests

Cellular Engineering

Research Disciplines

  • Cancer Biology
  • Cell and Developmental Biology
  • Chemical Engineering
  • Experimental Pathology

Research Opportunities

  • Cancer Biology
  • Cell Biology
  • Experimental Pathology

PhD Programs

  • Experimental Pathology

Selected Publications

2017

Janes, K. A., Chandran, P. L., Ford, R. M., Lazzara, M. J., Papin, J. A., Peirce, S. M., . . . Lauffenburger, D. A. (2017). An engineering design approach to systems biology. INTEGRATIVE BIOLOGY, 9(7), 574-583. doi:10.1039/c7ib00014f

2014

Fogelgren, B., Zuo, X., Buonato, J. M., Vasilyev, A., Baek, J. -I., Choi, S. Y., . . . Lipschutz, J. H. (2014). Exocyst Sec10 protects renal tubule cells from injury by EGFR/MAPK activation and effects on endocytosis.. American journal of physiology. Renal physiology, 307(12), F1334-F1341. doi:10.1152/ajprenal.00032.2014

2010

Lazzara, M. J., Lane, K., Chan, R., Jasper, P. J., Yaffe, M. B., Sorger, P. K., . . . Lauffenburger, D. A. (2010). Impaired SHP2-Mediated Extracellular Signal-Regulated Kinase Activation Contributes to Gefitinib Sensitivity of Lung Cancer Cells with Epidermal Growth Factor Receptor-Activating Mutations. CANCER RESEARCH, 70(9), 3843-3850. doi:10.1158/0008-5472.CAN-09-3421